Literature DB >> 35569929

Epstein-Barr Virus Dacryoadenitis in a Young Woman.

Tamami Watanabe1, Takeshi Yamashita1, Hitoshi Sugawara1.   

Abstract

Entities:  

Keywords:  Epstein-Barr virus; dacryoadenitis; young adults

Mesh:

Year:  2022        PMID: 35569929      PMCID: PMC9177378          DOI: 10.2169/internalmedicine.8004-21

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.282


× No keyword cloud information.
A 27-year-old woman with hypothyroidism and depression consulted for headache, ocular discharge, bilateral eye-ache, and eyelid swelling for 2 weeks. A physical examination showed the disappearance of upper eyelid crease, edema, bilateral superior eyelid redness (Picture A), cervical lymphadenopathies, and meningeal irritation. The total white blood cell count, atypical lymphocyte percentage, and aspartate and alanine aminotransferase levels were 9,260 /μL, 10%, 47 U/L, and 56 U/L, respectively. Orbital computed tomography showed swollen eyelids and lacrimal glands (Picture B). Short-T1 intervention recovery magnetic resonance imaging showed isointensity signals to the eyeball (Picture C), indicating acute dacryoadenitis (AD). Epstein-Barr virus (EBV) viral capsid antigen IgM, 1:20; VCA IgG, 1:1,280; EBV nuclear antigen IgG, negative; and EBV-DNA, 4.5×105 copies/mL supported bilateral AD associated with EBV infectious mononucleosis (IM). With supportive care, her eyelid edema and elevated liver enzymes subsided (Picture D) after 14 days. EBV targets B lymphocytes and epithelial cells. Dacryoadenitis occurs in IM (1) and affects one per million people annually (2). EBV infection should be considered in young adults with AD.
Picture.
The authors state that they have no Conflict of Interest (COI).
  2 in total

1.  Epstein-Barr virus dacryoadenitis.

Authors:  M N Rhem; K R Wilhelmus; D B Jones
Journal:  Am J Ophthalmol       Date:  2000-03       Impact factor: 5.258

2.  Infectious mononucleosis presenting with dacryoadenitis.

Authors:  N S Aburn; T J Sullivan
Journal:  Ophthalmology       Date:  1996-05       Impact factor: 12.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.